PTEN deficiency leads to hyperproliferation and probably plays a permissive role in carcinogenesis; additional events, usually in form of second mutation [e.g., in MYC (139) gene], is needed for malignant transformation—this is possible even in the absence of obesity. Here, PTEN is linked to obesity due to melanocortin 4 receptor deficiency.